12 HR azatadine maleate 1 mg / pseudoephedrine sulfate 120 mg Extended Release Oral Tablet [Trinalin Repetabs Tablets]
RxNorm 213547
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 213547 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: 12 HR azatadine maleate 1 mg / pseudoephedrine sulfate 120 mg Extended Release Oral Tablet [Trinalin Repetabs Tablets].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
12 HR azatadine maleate 1 mg / pseudoephedrine sulfate 120 mg Extended Release Oral Tablet [Trinalin Repetabs Tablets]
(Atom ID: 12372273)
SY